At the beginning of 2019, we kicked off the year with our new website and joined LinkedIn and the Twitter-sphere! And on our blog, we’ve highlighted PHDA projects, team members, events, and industry best practices, keeping everyone up to date on all things PHDA.
In August, we were proud to announce that we were teaming up with Amazon Web Services (AWS) to accelerate research across eight projects that have the potential to improve human health, all beginning with machine learning and the power of big data. You can learn more about this news in our press release and read about the eight projects that received support from AWS here and here.
Throughout the year, research teams supported by the PHDA have demonstrated progress and success through presentations and peer-reviewed publications. One example comes from Jim Coons and Phil Empey, who lead the MEDIvate project. In March, their work was published in the Journal of the American Pharmacists Association. The article described the deployment and testing of their innovative app, which facilitates sharing of medication and vaccine lists to prevent errors and improve transitions of care.
PI’s Daniel Nagin and Jonathan Elmer lead the “Real-Time Tool to Predict Clinical Outcomes After Cardiac Arrest” project. This April, the team published a report on their work describing the use of group-based trajectory modeling to estimate prognoses over time in the journal Resuscitation. Congratulations to all of the research teams who shared their progress and results this year!
The PHDA also had the opportunity to attend HLTH 2019, a national conference for industry leaders to explore and discuss the future of healthcare. The PHDA was represented in the UPMC booth and PHDA leaders Zariel Johnson and Don Taylor were able to engage with health systems and tech companies about the great work being done through the Alliance.
Our team is looking forward to what is to come in 2020! We continue to receive proposals from creative teams interested in improving various elements of healthcare and human health through data-driven approaches. We look forward to supporting new investigations led by collaborative, inter-disciplinary teams and working with current teams as they take the next steps in development and commercialization of their innovative solutions.